AstraZeneca has unveiled a 15 billion dollar investment plan in China, underscoring renewed commercial momentum between Beijing and London as the UK prime minister visits the country. The British Swedish pharmaceutical group said the investment, running through 2030, will expand medicines manufacturing and
China could become one of the first countries globally to approve a drug entirely designed by artificial intelligence, signalling a major shift in how new medicines are discovered and developed. Pharmaceutical executives say advances in AI and human genetics are accelerating China’s transition
China’s cell therapy sector is drawing renewed investor interest as NewCure Biotech raised more than 200 million yuan, or about $28 million, in a Series B financing round to accelerate development of its TCR T pipeline targeting solid tumors. The round was co
From trial and error to data driven discovery Drug discovery has traditionally been a slow and uncertain process shaped by trial and error. In China, artificial intelligence is changing this dynamic by introducing data driven methods that compress research timelines and improve decision
Artificial intelligence (AI) is increasingly transforming healthcare in China, reshaping hospital operations, diagnostics, treatment planning, and patient management. By leveraging advanced algorithms, big data analytics, and machine learning models, hospitals are improving efficiency, enhancing clinical accuracy, and delivering more personalized care. This integration
Mandi’s IPO plan arrives at a time when Hong Kong’s capital markets are experiencing a remarkable revival. According to data from the London Stock Exchange Group, equity capital activity in the city has reached around seventy three billion dollars so far this year,
China’s rapid rise in clinical research is reshaping the global pharmaceutical landscape. With its current clinical trial capacity now comparable to that of the United States, the country is increasingly viewed as a prime destination for cutting edge drug development, international collaboration and
A fossil find with global significance A newly identified fossil from China is reshaping scientists’ understanding of how large animals moved across the ancient Earth more than 250 million years ago. The remains belong to a previously unknown species of dicynodont, a group
A milestone moment for AI driven drug development China’s biotech sector has reached a landmark moment as Hangzhou based start-up MindRank advanced its weight loss drug into Phase 3 clinical trials. The development marks the first time a Category 1 new drug in
Longevity is about daily choices not miracles When people think about living longer, they often imagine breakthroughs in medicine or expensive treatments reserved for the few. According to longevity experts, the reality is far less dramatic and far more practical. A long and
